NO20055098D0 - Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser - Google Patents

Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Info

Publication number
NO20055098D0
NO20055098D0 NO20055098A NO20055098A NO20055098D0 NO 20055098 D0 NO20055098 D0 NO 20055098D0 NO 20055098 A NO20055098 A NO 20055098A NO 20055098 A NO20055098 A NO 20055098A NO 20055098 D0 NO20055098 D0 NO 20055098D0
Authority
NO
Norway
Prior art keywords
dihydrocarbamazepine
hydroxy
derivatives
treatment
affective disorders
Prior art date
Application number
NO20055098A
Other languages
English (en)
Other versions
NO20055098L (no
Inventor
Markus Schmutz
Ferenc Martenyl
Stefanie Zechner
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055098D0 publication Critical patent/NO20055098D0/no
Publication of NO20055098L publication Critical patent/NO20055098L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
NO20055098A 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser NO20055098L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45986403P 2003-04-02 2003-04-02
PCT/EP2004/003590 WO2004087168A1 (en) 2003-04-02 2004-04-01 Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders

Publications (2)

Publication Number Publication Date
NO20055098D0 true NO20055098D0 (no) 2005-11-01
NO20055098L NO20055098L (no) 2005-12-22

Family

ID=33131906

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055098A NO20055098L (no) 2003-04-02 2005-11-01 Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser

Country Status (18)

Country Link
US (1) US20070010508A1 (no)
EP (1) EP1613329A1 (no)
JP (1) JP2006522064A (no)
KR (1) KR20050121235A (no)
CN (1) CN1767834A (no)
AU (1) AU2004226827B2 (no)
BR (1) BRPI0409151A (no)
CA (1) CA2520828A1 (no)
IS (1) IS8094A (no)
MA (1) MA27762A1 (no)
MX (1) MXPA05010614A (no)
NO (1) NO20055098L (no)
NZ (1) NZ542555A (no)
RU (1) RU2367440C2 (no)
TN (1) TNSN05246A1 (no)
TW (1) TW200502222A (no)
WO (1) WO2004087168A1 (no)
ZA (1) ZA200507742B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
CA2607427C (en) * 2005-05-06 2015-11-24 Portela & C.A., S.A. Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
CN101217959A (zh) * 2005-05-06 2008-07-09 坡特拉有限公司 醋酸艾司利卡西平及其应用方法
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
GB2437078A (en) 2006-04-11 2007-10-17 Portela & Ca Sa 10-Acyloxy-5H-dibenzo[b,f]azepine-5-carboxamides & their asymmetric hydrogenation to the chiral 10,11-dihydro derivatives
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies
WO2009102962A2 (en) * 2008-02-13 2009-08-20 Targacept, Inc. Combination of alpha 7 nicotinic agonists and antipsychotics
CN116925238A (zh) 2009-02-03 2023-10-24 阿穆尼克斯制药公司 延伸重组多肽和包含该延伸重组多肽的组合物
US8703717B2 (en) 2009-02-03 2014-04-22 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US8680050B2 (en) 2009-02-03 2014-03-25 Amunix Operating Inc. Growth hormone polypeptides fused to extended recombinant polypeptides and methods of making and using same
US9849188B2 (en) 2009-06-08 2017-12-26 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
CN102188432B (zh) * 2011-04-07 2012-05-23 江立富 一种用于防治癫痫的药物
JP2013237676A (ja) * 2013-06-26 2013-11-28 Bial-Portela & Ca Sa 酢酸エスリカルバゼピン及び使用方法
CN105492442A (zh) * 2013-09-06 2016-04-13 日本曹达株式会社 内型-9-氮杂双环[3.3.1]壬烷-3-醇衍生物的制造方法
EP3064490A1 (en) 2015-03-06 2016-09-07 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
PT101732B (pt) * 1995-06-30 1997-12-31 Portela & Ca Sa Novas di-hidrodibenzo<b,f>azepinas substituidas processo para a sua preparacao composicoes farmaceuticas que as contem e utilizacao dos novos compostos na preparacao de composicoes farmaceuticas empregues em doencas do sistema nervoso
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
DE10036289A1 (de) 2000-07-26 2002-02-07 Bosch Gmbh Robert Elektronisch kommutierte elektrische Maschine, insbesondere Motor
JP2005511623A (ja) * 2001-11-12 2005-04-28 ノバルティス アクチエンゲゼルシャフト 情動および注意障害、神経因性疼痛の処置用医薬の製造において使用するためのモノヒドロキシカルバマゼピン

Also Published As

Publication number Publication date
ZA200507742B (en) 2008-07-30
AU2004226827B2 (en) 2008-04-03
CN1767834A (zh) 2006-05-03
MA27762A1 (fr) 2006-02-01
US20070010508A1 (en) 2007-01-11
BRPI0409151A (pt) 2006-03-28
WO2004087168A1 (en) 2004-10-14
AU2004226827A1 (en) 2004-10-14
JP2006522064A (ja) 2006-09-28
IS8094A (is) 2005-10-27
EP1613329A1 (en) 2006-01-11
NZ542555A (en) 2009-03-31
TNSN05246A1 (en) 2007-06-11
CA2520828A1 (en) 2004-10-14
KR20050121235A (ko) 2005-12-26
TW200502222A (en) 2005-01-16
MXPA05010614A (es) 2005-11-23
RU2367440C2 (ru) 2009-09-20
NO20055098L (no) 2005-12-22
RU2005133665A (ru) 2006-06-10

Similar Documents

Publication Publication Date Title
NO20055098D0 (no) Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
IS2722B (is) 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum
NO20053678D0 (no) Kombinasjonsterapi for behandling av immuninflammatoriske forstyrrelser
LTC1830843I2 (lt) Indolidono dariniai, skirti fibrozinių ligų gydymui arba prevencijai
CY2013022I1 (el) Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
NO20053384D0 (no) Benzazepinderivater for behandling av neurologiske forstyrrelser.
NO20052058D0 (no) Behandling av influensa.
CY2015025I1 (el) Μεθοδοι για την αντιμετωπιση της νοσου παρκινσον
LTC1562603I2 (lt) Nauji vaistai, skirti lėtinių obstrukcinių plaučių ligų gydymui
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20044054L (no) Administrering av midler for behandling av betennelse
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
SE531352C8 (sv) Spiroalkanderivat och användning av dessa föreningar för behandling av artrit, cancer, kardiovaskulära sjukdomar, hudsjukdomar och inflammatoriska och allergiska tillstånd
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
ITMI20031311A0 (it) Formulazioni per il trattamento di disturbi artrosici
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application